Re:Pair Genomics Inc.
Re:Pair Genomics Inc.
Vaughan, Ontario, Canada
Description

Re:Pair Genomics uses AI to design compact synthetic promoters, which are DNA sequences required for gene therapies to target specific cell types. Rather than spending six months to a year to design and validate promoters manually, our algorithm can produce designs ready for testing within a day.

Number of employees
11 - 50 employees
Industries
Science Technology
Representation
Minority-Owned Women-Owned Small Business Youth-Owned Immigrant-Owned

Recent projects

Enhancing Genomic Data Analysis with Machine Learning

Re:Pair Genomics Inc. is seeking to enhance its bioinformatics algorithms by integrating machine learning techniques to improve the accuracy and efficiency of genomic data analysis. The current algorithms, while effective, can benefit from the predictive power and adaptability of machine learning models. The project aims to identify specific areas within the existing bioinformatics pipeline where machine learning can be applied to optimize performance. Students will be tasked with researching and selecting appropriate machine learning models, training these models on existing genomic datasets, and evaluating their performance against current methods. The goal is to achieve a measurable improvement in data processing speed and accuracy, ultimately contributing to more precise genomic interpretations.

Admin Cole Keddie
Matches 1
Category Artificial intelligence + 2
Open

Bioinformatics Algorithm Enhancement with Machine Learning

Re:Pair Genomics Inc. is seeking to enhance its bioinformatics algorithms by integrating machine learning techniques. The project aims to improve the accuracy and efficiency of genomic data analysis, which is crucial for identifying genetic variations and understanding complex biological processes. Learners will apply their machine learning knowledge to develop and refine components of an existing algorithm used in genomic data processing. The project will involve analyzing existing datasets, identifying patterns, and implementing machine learning models to optimize algorithm performance. This initiative provides an opportunity for learners to bridge the gap between theoretical knowledge and practical application in the field of bioinformatics. The project is designed to be completed by a team of learners specializing in computer science or bioinformatics, ensuring a focused and cohesive approach.

Admin Shiron Lee
Matches 1
Category Machine learning + 4
Open

Grant and Pitch Preparation for Re:Pair Genomics Inc.

Re:Pair Genomics Inc., a biotech startup, is seeking to secure funding to advance its innovative solutions in the genomics field. The project aims to identify potential non-dilutive funding sources, including grants and pitch competitions, that align with the company's mission and objectives. The team will conduct research to compile a list of suitable funding opportunities and analyze the requirements for each. Additionally, the project involves assisting in the preparation of application materials, ensuring they are tailored to meet the specific criteria of each funding source. This project provides an opportunity for learners to apply their research, writing, and analytical skills in a real-world context, while gaining insight into the biotech industry's funding landscape.

Admin Shiron Lee
Matches 1
Category Project management + 2
Open

Grant and Pitch Preparation for Re:Pair Genomics Inc.

Re:Pair Genomics Inc., a biotech startup, is seeking to secure funding to advance its innovative solutions in the genomics field. The project aims to identify potential non-dilutive funding sources, including grants and pitch competitions, that align with the company's mission and objectives. The team will conduct research to compile a list of suitable funding opportunities and analyze the requirements for each. Additionally, the project involves assisting in the preparation of application materials, ensuring they are tailored to meet the specific criteria of each funding source. This project provides an opportunity for learners to apply their research, writing, and analytical skills in a real-world context, while gaining insight into the biotech industry's funding landscape.

Admin Cole Keddie
Matches 1
Category Grant writing + 2
Open

Latest feedback

Kanish Baskaran
Kanish Baskaran
Participant
May 11, 2025
Project feedback
Loved working with Shiron, Abena and the Re:Pair genomics team. Gained a lot of insight into the healthcare startup world and developed my research and business development skills. The team was nothing but friendly and supportive, and created many opportunities for me to self-direct my learning and develop my skills. Would recommend this company to any student looking for a healthy, growth-focused learning environment
Riipen Level UP 🚀
Level UP: March 2025
Riipen Level UP 🚀
Re:Pair Genomics Inc.
Grant and Pitch Preparation for Re:Pair Genomics Inc.
Re:Pair Genomics Inc.
Angela SiTu
She / Her
Participant
May 9, 2025
Project feedback
It was a pleasure to work with Shiron, Abena, and the rest of the Re:Pair team. It was a great opportunity to learn about start-up companies, grant applications and other business-related activities. Gaining a full perspective on how academia can integrate into industry has been an enlightening experience to participate in.
Riipen Level UP 🚀
Level UP: March 2025
Riipen Level UP 🚀
Re:Pair Genomics Inc.
Grant and Pitch Preparation for Re:Pair Genomics Inc.
Re:Pair Genomics Inc.
makaato serumaga
Participant
May 9, 2025
Project feedback
It was a great experience working with the team. Communication was clear and timely throughout the project, and I always felt supported in moving forward with each stage of the work. I really appreciated the thoughtful feedback and the balance between giving direction and allowing room for independent problem solving. The collaboration made the project both productive and enjoyable.
Riipen Level UP 🚀
Level UP: March 2025
Riipen Level UP 🚀
Re:Pair Genomics Inc.
Bioinformatics Algorithm Enhancement with Machine Learning
Re:Pair Genomics Inc.